SecBot SecBot
SECBOTREPLAY Home › Report › CRL

CRL · A cluster of insider selling at Charles River Laboratories (CRL)…

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CLUSTER filed Aug 13, 2026 at 16:37 ET

At the news

NEUTRALIMPACT 3/10

CLUSTER filed Aug 13, 2026 at 16:37 ET

A cluster of insider selling at Charles River Laboratories (CRL) totaling $10.21M occurred within 9 days of the Q2 2026 earnings beat. The selling is concentrated among a director (Foster, $7.9M), a CEVP (Parisotto, $1.04M), and an EVP (Creamer, $1.08M), all of which are open-market sales. While the earnings report was bullish (beat on EPS, raised guidance), the insider sales are likely liquidity-driven, as they coincide with option exercises and vesting, and the total value represents only 0.075% of the $13.6B market cap, falling below the 0.1% materiality threshold. The cluster is not a bearish signal given the small proportional size and the context of post-earnings window openings, but it warrants monitoring for any follow-on sales by the CEO or CFO.

  • Insider cluster of 4 executives sold $10.21M in open-market sales over a 7-day window.
  • Director James C. Foster accounted for $7.9M (77%) of the total selling.
  • Total sales represent only 0.075% of CRL's $13.6B market cap, below the 0.1% materiality threshold.
  • Sales occurred 9 days after a bullish Q2 earnings report (EPS beat by 10.6%, raised guidance).

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access